Expression, crystallization and preliminary crystallographic data analysis of filamin A repeats 14-16.

Acta Crystallogr Sect F Struct Biol Cryst Commun

Department of Medical Biochemistry and Microbiology, Uppsala University, Sweden.

Published: April 2007

Human filamin A is a 280 kDa protein involved in actin-filament cross-linking. It is structurally divided into an actin-binding headpiece (ABD) and a rod domain containing 24 immunoglobulin-like (Ig) repeats. A fragment of human filamin A (Ig repeats 14-16) was cloned and expressed in Escherichia coli and the purified protein was crystallized in 1.6 M ammonium sulfate, 2% PEG 1000 and 100 mM HEPES pH 7.5. The crystals diffracted to 1.95 A and belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 50.63, b = 52.10, c = 98.46 A, alpha = beta = gamma = 90 degrees.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2330200PMC
http://dx.doi.org/10.1107/S1744309107006689DOI Listing

Publication Analysis

Top Keywords

filamin repeats
8
repeats 14-16
8
human filamin
8
expression crystallization
4
crystallization preliminary
4
preliminary crystallographic
4
crystallographic data
4
data analysis
4
analysis filamin
4
14-16 human
4

Similar Publications

Filamin A C-terminal fragment modulates Orai1 expression by inhibition of protein degradation.

Am J Physiol Cell Physiol

January 2025

Department of Physiology (Cellular Physiology Research Group),Institute of Molecular Pathology Biomarkers (IMPB), University of Extremadura, 10003-Caceres, Spain.

Filamin A (FLNA) is an actin-binding protein that has been reported to interact with STIM1 modulating the activation of Orai1 channels. Cleaving of FLNA by calpain leads to a C-terminal fragment that is involved in a variety of functional and pathological events, including pro-oncogenic activity in different types of cancer. Here we show that full-length FLNA is downregulated in samples from colon cancer patients as well as in the adenocarcinoma cell line HT-29.

View Article and Find Full Text PDF

The hinge-1 domain of Flna is not necessary for diverse physiological functions in mice.

Eur J Clin Invest

December 2024

Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Introduction: The filamins are cytoskeletal binding proteins that dynamically crosslink actin into orthogonal networks or bundle it into stress fibres. The domain structure of filamin proteins is very well characterised, with an N-terminal actin-binding region, followed by 24 immunoglobulin-like repeat units. The repeat domains are separated into distinct segments by two regions of low-complexity known as hinge-1 and hinge-2.

View Article and Find Full Text PDF

Human cancers express altered levels of actin-binding cytoskeletal filamin A (FLNA) protein. FLNA in mammals consists of an actin-binding domain at its N-terminus that is followed by 24 immunoglobulin-like repeat modules interrupted by two hinge regions between repeats 15-16 and 23-24. Cleavage of these hinge regions produces a naturally occurring C-terminal 90 kDa fragment of FLNA (FLNA) that physically interacts with multiple proteins with diverse functions.

View Article and Find Full Text PDF
Article Synopsis
  • Microvesicles released by endothelial cells contain tissue factor (TF) and enhance the migration of human coronary artery smooth muscle cells (HCASMC), with phosphorylation of TF at Ser253 playing a significant role.
  • The study showed that endothelial-derived TF-MV accelerate HCASMC migration, but this effect decreases if TF's cytoplasmic domain is deleted.
  • Blocking TF-fVIIa activity or inhibiting PAR2 signaling stops the enhanced migration, indicating a complex interaction between these factors and their importance in vascular health and disease.
View Article and Find Full Text PDF

Pathogenic FLNA variants affecting the hinge region of filamin A are associated with male survival.

Am J Med Genet A

October 2024

Department of Women's and Children's Health, Dunedin School of Medicine, Otago University, Dunedin, New Zealand.

Article Synopsis
  • Pathogenic variants in the FLNA gene lead to various X-linked developmental disorders, influenced by either increased or decreased filamin A protein levels, which can be understood as gain- or loss-of-function issues.
  • Embryonic lethality is typically associated with hemizygosity for deletions or truncating variants in FLNA, but the study reveals that three specific variants involving the hinge-1 region result in distinct clinical conditions without causing embryonic death in affected males.
  • The findings suggest that while hinge-1 typically provides flexibility to filamin A and is involved in important cellular signaling, its impairment can lead to viable, albeit varied, phenotypes instead of lethal outcomes in male patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!